RESPONSE: Seladelpar Normalizes Alkaline Phosphatase, Reduce

Results from the phase 3 trial showed seladelpar elicited biochemical response, normalized alkaline phosphatase, and reduced pruritus at a greater rate than placebo.

Related Keywords

Toronto , Ontario , Canada , David Assis , Terry Horner , Gideon Hirschfield , Yale School Of Medicine , Autoimmune Liver Disease Research , Drug Administration , University Of Toronto , Foundation Gideon Hirschfield , New England Journal , Yale School , Cymabay Therapeutic New Drug Application , Priority Review , Prescription Drug User Fee Act , Terry Horner Chair , Primary Biliary , Improves Markers , Second Line Treatment , Cpbc , Primary Biliary Cholangitis , Seladelpar , Biochemical Response , Alkaline Phosphatase , Normalization , Pruritus , Ursodeoxycholic Acid , Obeticholic Acid ,